Indication
Lymphomatous meningitis
Lymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system. Read more about Lymphomatous meningitis
1 drugs 1 manufacturers
Drugs that treat it
Common Lymphomatous meningitis therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system.
It primarily occurs as a secondary metastatic complication of aggressive systemic non-Hodgkin lymphomas, though it can also arise in the setting of primary central nervous system lymphoma.
Pathophysiologically, the tumor cells seed the subarachnoid space, disrupting cerebrospinal fluid dynamics and prompting multifocal inflammation across the entire neuraxis.
This diffuse involvement leads to varied neurological deficits, typically presenting with combinations of cranial neuropathies, radicular pain or motor weakness, altered mental status, and symptoms of elevated intracranial pressure such as persistent headache, nausea, and vomiting.
- cancer.gov
Lymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system Pathophysiologically, the tumor cells seed the subarachnoid space, disrupting cerebrospinal fluid dynamics and prompting multifocal inflammation across the entire neuraxis
- nih.gov
Lymphomatous meningitis is a severe neuro-oncologic manifestation characterized by the dissemination and infiltration of malignant lymphoid cells into the leptomeninges and cerebrospinal fluid compartments of the central nervous system It primarily occurs as a secondary metastatic complication of aggressive systemic non-Hodgkin lymphomas, though it can also arise in the setting of primary central nervous system lymphoma Pathophysiologically, the tumor cells seed the subarachnoid space, disruptin...
- nih.gov
It primarily occurs as a secondary metastatic complication of aggressive systemic non-Hodgkin lymphomas, though it can also arise in the setting of primary central nervous system lymphoma
- nih.gov
This diffuse involvement leads to varied neurological deficits, typically presenting with combinations of cranial neuropathies, radicular pain or motor weakness, altered mental status, and symptoms of elevated intracranial pressure such as persistent headache, nausea, and vomiting
- cancer.gov
This diffuse involvement leads to varied neurological deficits, typically presenting with combinations of cranial neuropathies, radicular pain or motor weakness, altered mental status, and symptoms of elevated intracranial pressure such as persistent headache, nausea, and vomiting
Personalize your experience
Follow Lymphomatous meningitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.